Cargando…

Practical Considerations for Use of Direct Oral Anticoagulants in Children

Direct oral anticoagulants (DOACs) provide an attractive alternative for the management and prevention of thrombosis in pediatric patients. With multiple ongoing and published pediatric trials and recent regulatory approval of dabigatran and rivaroxaban, the landscape of pediatric anticoagulation is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitworth, Hilary, Raffini, Leslie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010784/ https://www.ncbi.nlm.nih.gov/pubmed/35433559 http://dx.doi.org/10.3389/fped.2022.860369

Ejemplares similares

Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children
por: Dain, Aleksandra S., et al.
Publicado: (2022)

Prevention of Hospital-Acquired Venous Thromboembolism in Children: A Review of Published Guidelines
por: Faustino, E. Vincent S., et al.
Publicado: (2017)

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
por: Al-Ghafry, Maha, et al.
Publicado: (2022)

Considerations for use of direct oral anticoagulants in arterial disease
por: Siegal, Deborah M., et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians
por: Peacock, W. Frank, et al.
Publicado: (2016)

Direct oral anticoagulants in pediatric venous thromboembolism: Experience in specialized pediatric hemostasis centers in the United States
por: Corrales-Medina, Fernando F., et al.
Publicado: (2022)

Utilization and prescribing patterns of direct oral anticoagulants
por: Whitworth, Maegan M, et al.
Publicado: (2017)

Accessibility Considerations in the National Children's Study
por: Harniss, Mark, et al.
Publicado: (2021)

Methodological and Statistical Considerations for the National Children's Study
por: Hays, Ron D., et al.
Publicado: (2021)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

COVID-19: Considerations for Children and Families During the Pandemic
por: Tang, Binzhi, et al.
Publicado: (2021)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

FOXN1 Gene Considerations in Severe Combined Immunodeficiency Treatment in Children
por: Torres, Stephanie, et al.
Publicado: (2022)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
por: Hu, Fang, et al.
Publicado: (2022)

Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
por: Lutz, Jens, et al.
Publicado: (2017)

Direct oral anticoagulant failure in stroke/transient ischaemic attack: neurologic and pharmacokinetic considerations
por: Rose, David Z, et al.
Publicado: (2020)

Clinical application of regional citrate anticoagulation for membrane-based therapeutic plasma exchange in children with liver failure
por: Hu, Jun, et al.
Publicado: (2023)

Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
por: Haji Rahman, Rangin, et al.
Publicado: (2023)

Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations
por: Stankunaite, Reda, et al.
Publicado: (2022)

Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight
por: Undas, Anetta
Publicado: (2016)

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
por: Chen, Ashley, et al.
Publicado: (2020)

Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients
por: How, Joan, et al.
Publicado: (2021)

Response to editorial comment ‘Direct oral anticoagulant failure in TIA/stroke: neurologic and pharmacokinetic considerations’
por: Huynh, Ronald, et al.
Publicado: (2020)

Outcomes in infants with unprovoked venous thromboembolism: A retrospective cohort study
por: Whitworth, Hilary, et al.
Publicado: (2023)

Alternative to oral dicoumarin anticoagulants: Considerations in dental care
por: Mingarro-de-León, Ana, et al.
Publicado: (2013)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Malnutrition and Associated Risk Factors Among Disabled Children. Special Considerations in the Pediatric Surgical “Fragile” Patients
por: Pelizzo, Gloria, et al.
Publicado: (2019)

Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
por: Cashen, Katherine, et al.
Publicado: (2019)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
por: Sun, Yuelin, et al.
Publicado: (2023)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
por: Giannandrea, David, et al.
Publicado: (2019)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
por: Toth, Peter P
Publicado: (2016)

Surfacing undiagnosed disease: consideration, counting and coding
por: Baxter, Megan F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4k1od8pbjs63jqo197un55r05i